• Je něco špatně v tomto záznamu ?

Providing Biological Plausibility for Exposure-Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework

AD. van den Brand, L. Bajard, IL. Steffensen, AL. Brantsæter, HAAM. Dirven, J. Louisse, A. Peijnenburg, S. Ndaw, A. Mantovani, B. De Santis, MJB. Mengelers

. 2022 ; 14 (4) : . [pub] 20220413

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018799

Humans are chronically exposed to the mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1), as indicated by their widespread presence in foods and occasional exposure in the workplace. This exposure is confirmed by human biomonitoring (HBM) studies on (metabolites of) these mycotoxins in human matrices. We evaluated the exposure-health relationship of the mycotoxins in humans by reviewing the available literature. Since human studies did not allow the identification of unequivocal chronic health effects upon exposure to DON and FB1, the adverse outcome pathway (AOP) framework was used to structure additional mechanistic evidence from in vitro and animal studies on the identified adverse effects. In addition to a preliminary AOP for DON resulting in the adverse outcome (AO) 'reduced body weight gain', we developed a more elaborated AOP for FB1, from the molecular initiating event (MIE) 'inhibition of ceramide synthases' leading to the AO 'neural tube defects'. The mechanistic evidence from AOPs can be used to support the limited evidence from human studies, to focus FB1- and DON-related research in humans to identify related early biomarkers of effect. In order to establish additional human exposure-health relationships in the future, recommendations are given to maximize the information that can be obtained from HBM.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018799
003      
CZ-PrNML
005      
20220804135110.0
007      
ta
008      
220720s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/toxins14040279 $2 doi
035    __
$a (PubMed)35448888
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a van den Brand, Annick D $u Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands $1 https://orcid.org/0000000283965494
245    10
$a Providing Biological Plausibility for Exposure-Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework / $c AD. van den Brand, L. Bajard, IL. Steffensen, AL. Brantsæter, HAAM. Dirven, J. Louisse, A. Peijnenburg, S. Ndaw, A. Mantovani, B. De Santis, MJB. Mengelers
520    9_
$a Humans are chronically exposed to the mycotoxins deoxynivalenol (DON) and fumonisin B1 (FB1), as indicated by their widespread presence in foods and occasional exposure in the workplace. This exposure is confirmed by human biomonitoring (HBM) studies on (metabolites of) these mycotoxins in human matrices. We evaluated the exposure-health relationship of the mycotoxins in humans by reviewing the available literature. Since human studies did not allow the identification of unequivocal chronic health effects upon exposure to DON and FB1, the adverse outcome pathway (AOP) framework was used to structure additional mechanistic evidence from in vitro and animal studies on the identified adverse effects. In addition to a preliminary AOP for DON resulting in the adverse outcome (AO) 'reduced body weight gain', we developed a more elaborated AOP for FB1, from the molecular initiating event (MIE) 'inhibition of ceramide synthases' leading to the AO 'neural tube defects'. The mechanistic evidence from AOPs can be used to support the limited evidence from human studies, to focus FB1- and DON-related research in humans to identify related early biomarkers of effect. In order to establish additional human exposure-health relationships in the future, recommendations are given to maximize the information that can be obtained from HBM.
650    12
$a dráhy škodlivých účinků $7 D000073931
650    _2
$a zvířata $7 D000818
650    _2
$a viabilita buněk $7 D002470
650    12
$a fumonisiny $x toxicita $7 D037341
650    _2
$a lidé $7 D006801
650    12
$a mykotoxiny $x farmakologie $7 D009183
650    _2
$a trichotheceny $7 D014255
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bajard, Lola $u RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, 611 37 Brno, Czech Republic $1 https://orcid.org/0000000190027095
700    1_
$a Steffensen, Inger-Lise $u Norwegian Institute of Public Health (NIPH), 0213 Oslo, Norway $1 https://orcid.org/0000000218590083
700    1_
$a Brantsæter, Anne Lise $u Norwegian Institute of Public Health (NIPH), 0213 Oslo, Norway $1 https://orcid.org/0000000163157134
700    1_
$a Dirven, Hubert A A M $u Norwegian Institute of Public Health (NIPH), 0213 Oslo, Norway $1 https://orcid.org/0000000276869947
700    1_
$a Louisse, Jochem $u Wageningen Food Safety Research (WFSR), 6708 WB Wageningen, The Netherlands $1 https://orcid.org/0000000205172288
700    1_
$a Peijnenburg, Ad $u Wageningen Food Safety Research (WFSR), 6708 WB Wageningen, The Netherlands $1 https://orcid.org/0000000257380097
700    1_
$a Ndaw, Sophie $u Institut National de Recherche et de Sécurité (INRS), 54500 Vandoeuvre-Lés-Nancy, France $1 https://orcid.org/0000000275182465
700    1_
$a Mantovani, Alberto $u Istituto Superiore di Sanità (ISS), 00161 Rome, Italy $1 https://orcid.org/0000000314490330
700    1_
$a De Santis, Barbara $u Istituto Superiore di Sanità (ISS), 00161 Rome, Italy $1 https://orcid.org/0000000342102796
700    1_
$a Mengelers, Marcel J B $u Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands $1 https://orcid.org/0000000293121164
773    0_
$w MED00177194 $t Toxins $x 2072-6651 $g Roč. 14, č. 4 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35448888 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135104 $b ABA008
999    __
$a ok $b bmc $g 1822413 $s 1170042
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 4 $e 20220413 $i 2072-6651 $m Toxins $n Toxins $x MED00177194
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace